ACCC | CMS Releases C-Code for Belantamab Mafodotin-blmf
CMS Releases C-Code for Belantamab Mafodotin-blmf
The Centers for Medicare and Medicaid Services (CMS) released the C-code C9369 (injection, belantamab mafodontin-blmf, 0.5 mg) for GlaxoSmitheKline's Blenrep (belantamab mafodotin-blmf), effective January 1, 2021.
In Person April 22, 2027 at 8:00 AM EDTInterContinental the Willard Washington D.C. by IHG, 1401 Pennsylvania Ave NW, Washington, DC 20004, USAWillard Intercontinental,
From Diagnosis to Survivorship: Understanding AML and CLL From End to End
In recognition of Leukemia and Lymphoma Awareness Month, ACCC compiled a group of resources to help care teams navigate two of the most commonly diagnosed adult leukemias: acute myeloid leukemia and chronic lymphocytic leukemia.
